Please ensure Javascript is enabled for purposes of website accessibility

Live: Coronavirus Market Crash Coverage

The Motley Fool’s live guide on what investors should do during the stock market crash and the COVID-19 pandemic.

We’ve created this page for all investors seeking advice on what they should be doing in this turbulent period. Our most important content can be found in the Editors' Picks, section.

We do believe this will all end up behind us, because we view investing as a long-term endeavor. Borrowing from Warren Buffett: "We have no idea -- and never have had -- whether the market is going to go up, down, or sideways in the near- or intermediate-term future." However, we firmly believe investors will be rewarded over the long term.

We suggest bookmarking this page as we will update our Editors' Picks periodically -- the Recent Articles section is a live feed of our latest thinking. Finally, we understand that many people are seeking epidemiological information on COVID-19. For that we strictly suggest visiting the information pages set up by the CDC and WHO.

For members of The Motley Fool's investing services, you can access all our Coronavirus market coverage at fool.com/premium after logging in.

Recent articles

Worried woman with laptop

Is a Meltdown on the Way for Moderna Stock?

There are certainly reasons to think the biotech stock is overpriced right now.


Vaccine being given to young woman by female doctor

3 Big Hints That COVID Vaccine Booster Doses Are on the Way

The writing could already be on the wall.


Delta variant sign with dark clouds

Worries About the Delta Variant Could Be Overdone Based on Clues From These Healthcare Giants

What healthcare executives are saying so far about the impact of the coronavirus variant on their businesses is reassuring.


Vaccine bottles forming a dollar sign

200 Million More Reasons to Buy Pfizer Stock

The giant drugmaker just landed another big supply deal.


Doctor with vaccine syringe and question mark

Is It Too Late to Buy Novavax Stock?

The answer is in the first two letters of the vaccine maker's name.


Dollar signs above a businessman's hands

How in the World Is Moderna Valued at More Than Half of Pfizer's Market Cap?

There are four possible answers.


Vaccine being given to young man

Are Booster Doses of Pfizer's and Moderna's COVID Vaccines on the Way?

It's only a maybe for now.


Stock market quotes

Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?

There's no guarantee that the biotech's share price will continue climbing.


Arrow pointing down, dollar sign, green arrow pointing up

This Stock Should Soar If the Stock Market Crashes This Summer

It's the most likely winner benefiting from the most likely reason that an imminent crash might occur.


Dividends bag under umbrella

3 Things Every Investor Should Know About Pfizer's Dividend

Hint: There's a lot to like.


GettyImages-839900080

2 Under-the-Radar Stocks to Buy Now

The stocks have huge upside potential that investors are overlooking.


Coronavirus with stock chart trending down

Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week

The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.


COVID vaccine with dollar sign

Why Moderna Stock Is Hitting Another Record High Today

The vaccine stock benefited from two positive developments.


Vaccine with world map

Moderna's Big Step Toward Dominating the Vaccine Market

It's still only an early step, though.


COVID-19 vaccine montage

Why Ocugen Stock Skyrocketed 339% in the First Half of 2021

The big jump resulted from the company's partnership with Bharat Biotech to commercialize COVID-19 vaccine Covaxin.


COVID vaccine vial, syringe, and stock chart

Why Novavax Stock Soared 90% in the First Half of 2021

Investors were increasingly confident that the company's COVID-19 vaccine would be successful.


COVID-19 Delta variant road signs

What Pfizer, BioNTech, and Moderna Are Doing to Fight the Deadly Delta Variant

The short answer: A lot.


Vaccine being given to a young man

How Johnson & Johnson's COVID Vaccine Is Making a Comeback

Things are finally looking up for the healthcare giant's COVID-19 vaccine.


3 syringes

Why the CDC and FDA Just Slapped Down Pfizer and Moderna

There's a bit of a brouhaha over booster doses.


Coronavirus with earth inside it

Why Moderna and Novavax Stocks Are Jumping Today

COVID-19 concerns are driving the vaccine stocks higher.